From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest

GoldfishShark

Video: Gold and Inflation

Analyst Jeffrey Christian admits that folks do not agree about what will happen next.  He discusses his recent presentation at the Silver Symposium and how his opinions differ. He notes that all currencies are fiat and that gold’s value is determined by fiat. Much in the same way that currencies are valued by national central banks.

GoldfishShark

Andrew Monk’s VSA Resources to list on Aquis – why will it be different this time Monkey?

Fresh from its less than flattering role in the Tim Yeo/TMO Renewables trial, Andrew Monk’s VSA Resources has today announced its intention to float on the Aquis lobster pot which Monkey laughably predicts will be Europe’s Nasdaq. You may be tempted because the last accounts show that VSA had a cracking year to March 31 2021. But hang on? Wasn’t VSA once on AIM?

GoldfishShark

Video: Equity Valuations have Never Been Higher

Money manager Ted Oakley says US job numbers may appear to be improving but it’s hard to measure real employment numbers accurately. The jobs and family act need to be passed so that society at large obtain some return on that money. America needs to stop paying people to stay home. So a fake economy has been created meaning valuations of all asset classes are way beyond stretched.

GoldfishShark

Creightons – possible offer to Innovaderma, what now after approach “unequivocally rejected”?...

Creightons (CRL) has announced that a possible offer approach last week to Innovaderma (IDP) has been “unequivocally rejected… without affording Creightons the benefit of any further discussion” but that it continues to have a serious interest in a deal and now makes an announcement “in order that the shareholders of Innovaderma are directly aware of Creightons' interest”. With shares in Creightons currently down 2% to 64.5p and in Innovaderma up 14% to 48.5p, what’s the detail?...

Page 2 of 3 (21 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments